| Literature DB >> 32581540 |
Malahat Akbarfahimi1, Seyed Massood Nabavi2, Benyamin Kor3, Leeba Rezaie4, Ethan Paschall5.
Abstract
PURPOSE: Sleep difficulties are common in patients with multiple sclerosis (MS), which may increase feelings of fatigue, negatively interfere with daily activities, and consequently reduce their quality of life. Studies examining the effects of sleep-targeted interventions in MS are currently limited in the literature. Therefore, we aim to assess the effects of occupational therapy interventions on sleep quality, fatigue, and quality of life in patients with MS. PATIENTS AND METHODS: In a single-blind, randomized, controlled trial, which occurred between April 2018 and March 2019 in Tehran, Iran, 20 eligible patients with MS were assessed using the Pittsburgh Sleep Quality Index (PSQI), Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), and Short-Form Health Survey (SF-36). Patients were allocated randomly into the two following groups: patients receiving care-as-usual for MS (CAU) and patients receiving care-as-usual plus intervention (CAU + intervention). Both intervention groups underwent 2-3 sessions per week lasting 30-45 minutes for 8 weeks and received follow-up assessments. Data were analyzed using independent sample t-tests and Mann-Whitney U tests using SPSS (16 ver.) statistical software.Entities:
Keywords: fatigue; multiple sclerosis; occupational therapy; quality of life; sleep interventions; sleep quality
Year: 2020 PMID: 32581540 PMCID: PMC7269630 DOI: 10.2147/NDT.S249277
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1Flowchart utilized in the study.
Abbreviation: CAU, care-as-usual.
The Program of Sleep Intervention Based on OT
| Sessions | Interventions |
|---|---|
| First | Education regarding sleep disorders. |
| Second | Set daily schedule based on the occupational profile. |
| Third | Encourage health management behaviors such as smoking cessation, reduced caffeine intake, eating too much at nights, adopting a balanced diet, and engaging in adequate exercise. |
| Fourth | Discuss the occupational balance and keeping busy during the day. |
| Fifth | Review cognitive behavioral exercises, modification, and discuss activities of daily living and home modification. |
| Sixth | Physical exercise as explained in the first session and ask about the balance of occupations. |
| Seventh | The last modifications and final consultations |
| Eighth | Review all exercises, trainings, and final advice. Receive feedback. |
The Mean (SD) of Character of Participants by CAU and CAU + Intervention Group at Baseline
| Characteristics | CAU | CAU+Interv. | |
|---|---|---|---|
| Mean (SD) | Mean (SD) | ||
| Age | 39.7(7.90) | 37.5(8.89) | 0.57** |
| EDSS | 1.2 (1.03) | 1.6 (0.97) | 0.38** |
| PSQI | 12.8(2.86) | 15.2(2.44) | 0.06** |
| SSQ | 2.3(0.48) | 2.3(0.48) | 0.66* |
| SL | 2.5(0.71) | 2.5(0.71) | 1* |
| SDU | 2.1(0.74) | 2.1(0.74) | 0.18* |
| SE | 2(0.94) | 2(0.94) | 0.16* |
| SDB | 1.7(0.67) | 1.7(0.67) | 0.33* |
| USM | 0.4(0.96) | 0.4(0.96) | 0.19* |
| DD | 1.8(0.79) | 1.8(0.79) | 0.27* |
| FIS | 80(18.93) | 97(15.53) | 0.04** |
| FSS | 5.98(0.86) | 6.26(0.79) | 0.46** |
| PCS | 159.5(50.1) | 148.3(37.13) | 0.58** |
| MCS | 162.4(28.6) | 150.5(29.04) | 0.37** |
The Within-Group and Between-Group Analysis of the Pittsburgh Sleep Quality Index, Fatigue Impact Scale, Fatigue Severity Scale, and SF-36 Scores in Two Groups, CAU Group (n=10) and CAU + Intervention Group (n=10)
| Variables | CAU Group | Within-Group | CAU+Interv. Group | Within-Group | Between Groups After Treatment | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline Mean (SD) | Outcome Mean (SD) | Baseline Mean (SD) | Outcome Mean (SD) | Mean Difference (SE) | Effect Size | |||||
| PSQI | SSQ | 2.3(0.48) | 2.3(0.48) | 1* | 2.4(0.52) | 1(0) | 0.004* | −1.3(0.15) | <0.001*** | 0.90 |
| SL | 2.5(0.71) | 2.6(0.70) | 0.317* | 2.5(0.97) | 1.4(0.70) | 0.009* | −1.2(0.31) | 0.003*** | 0.48 | |
| SDU | 2.1(0.74) | 2.1(0.74) | 1* | 2.5(0.53) | 1.2(0.42) | 0.004* | −0.9(0.27) | 0.011*** | 0.39 | |
| SE | 2(0.94) | 2(0.94) | 1* | 2.5(0.52) | 1.4(0.52) | 0.005* | −0.6(0.34) | 0.19*** | – | |
| SDB | 1.7(0.67) | 2.1(0.73) | 0.206* | 2(0.67) | 1.2(0.63) | 0.023* | −0.9(0.31) | 0.02*** | 0.32 | |
| USM | 0.4(0.96) | 0(0) | 0.180* | 1.1(1.23) | 0(0) | 0.024* | 0(0) | 1*** | – | |
| DD | 1.8(0.79) | 2.1(0.74) | 0.317* | 2.2(0.79) | 0.9(0.32) | 0.006* | −1.2(0.25) | 0.001*** | 0.61 | |
| Total | 12.8(2.85) | 13.2(3.48) | 0.42** | 15.2(2.44) | 7.2(1.03) | <0.001** | −6(1.15) | <0.001**** | 0.60 | |
| FIS | CFI | 13.5(7.2) | 14.8(7.61) | 0.041** | 20.5(5.97) | 11.5(4.24) | 0.008* | −13.3(2.8) | <0.001*** | 0.68 |
| PFI | 27.4(2.99) | 29.9(4.36) | 0.059* | 29.3(5.33) | 17.6(4.94) | 0.005* | −12.3(2.1) | <0.001*** | 0.76 | |
| SFI | 39.3(10.11) | 42.9(12.6) | 0.050* | 47.2(9.49) | 24.6(8.40) | 0.005* | −18.3(4.8) | <0.001*** | 0.72 | |
| Total | 80.2(18.94) | 87.6(21.52) | 0.012** | 97(15.53) | 53.7(13.57) | <0.001** | −33.9(8.04) | <0.001**** | 0.82 | |
| FSS | Total | 5.97(0.86) | 6.52(0.46) | 0.018** | 6.3(0.79) | 4.67(1.05) | 0.005** | −1.85(0.36) | <0.001**** | 0.76 |
| SF-36 | PF | 50 (21.86) | 44.5(18.92) | 0.026* | 50.5(21.92) | 76(16.12) | 0.005* | 31.5(7.86) | <0.001*** | 0.76 |
| RP | 25(23.57) | 15(17.4) | 0.414* | 12.5(17.68) | 55(34.9) | 0.241* | 40(12.4) | 0.001*** | 0.61 | |
| RE | 20(17.21) | 10(16.1) | 0.083* | 6.67(14.05) | 76.7(16.11) | 0.005* | 66.65(7.2) | <0.001*** | 0.80 | |
| VT | 38(7.89) | 35.5(8.32) | 0.096* | 36(9.66) | 53.3(8.82) | 0.005* | 17.75(3.83) | <0.001*** | 0.76 | |
| MH | 54.4(10.19) | 56.4(11.1) | 0.518* | 50.33(12.9) | 70.8(8.65) | 0.005* | 14.4(4.44) | 0.001*** | 0.58 | |
| SF | 50(10.21) | 50 (10.2) | 1* | 57.5(13.44) | 65(14.2) | 0.084* | 15(5.52) | 0.143*** | - | |
| BP | 52(16.24) | 52(16.3) | 0.317* | 50.8(12.42) | 65(11.1) | 0.018* | 13.05(6.22) | 0.004*** | 0.51 | |
| GH | 32.49(12.2) | 32.5(12.2) | 0.317* | 34.6(11.46) | 45.4(16.84) | 0.035* | 12.92(6.58) | 0.02*** | 0.34 | |
| SF | PCS | 159.5(50.1) | 143.9(48.3) | 0.087** | 148.3(37.13) | 241.41(38.1) | <0.001** | 113.8(13.9) | <0.001**** | 0.67 |
| MCS | 162.4(28.6) | 151.9(24.9) | 0.174** | 150.5(29.04) | 265.7(35.9) | <0.001** | 97.47(19.4) | <0.001**** | 0.82 | |
Notes: Data were presented as mean (standard deviation) and mean difference (Std. Error Difference). *Wilcoxon Signed Ranks Test; **Paired t-test; ***Mann–Whitney U; ****independent T.
Abbreviations: PSQI, The Pittsburgh Sleep Quality Index; SSQ, subjective sleep quality; SL, sleep latency; SDU, sleep duration; SE, sleep efficiency; SDB, sleep disturbance; USM, use of sleep medication; DD, daytime dysfunction; FIS, Fatigue Impact Scale; CFI, cognitive part of Fatigue Impact Scale; PFI, physical part of Fatigue Impact Scale; SFI, social part of Fatigue Impact Scale; FSS, fatigue Severity Scale; SF-36, The Short Form (36) Health Survey; PF, physical functioning; RP, role limitations due to physical health; RE, role limitations due to emotional problems; VT, energy/fatigue; MH, emotional well-being; SF, social functioning; BP, bodily pain; GH, general health; PCS, physical health component; MCS, mental health component score; CAU, care-as-usual in occupational therapy; CAU+ Interv., care-as-usual in occupational therapy + sleep intervention; SF-36 Sum, SF36 summary.